Vivos Therapeutics, Inc.VVOSEarnings & Financial Report
Nasdaq · biotechnology
Beam Therapeutics Inc. is an American biotechnology company conducting research in the field of gene therapies and genome editing. The company is headquartered in Cambridge, Massachusetts. In the development of therapies, the company relies on CRISPR base editing and prime editing, whereby single nucleotides in a DNA sequence can be enzymatically modified without producing double-strand breaks.
Top Holders
| Holder | % Owned | Shares | Change | As of |
|---|---|---|---|---|
| Armistice Capital, LLC | 4.99% | 250.3K | ▼ -5.00pp | 2024-11-14 |
| Coronado V Partners, LLC | 3.20% | 69.6K | — | 2024-02-14 |
| Ionic Ventures, LLC | 1.80% | 83.0K | ▼ -6.90pp | 2024-11-14 |
Insider Transactions
Net 90d: +$1.81M · buys $1.81M / sells $0Range:
Action:
Role:
| Insider | Role | Action | ||||
|---|---|---|---|---|---|---|
| 2026-03-31 | Skaff Michael C | 10% Owner | Buy (open market) | 1.04M | $1.34 | $1.40M |
| 2026-03-31 | Skaff Michael C | 10% Owner | Buy (open market) | 308.8K | $1.34 | $413.9K |
1–2 of 2